Cardiovascular Disease (CVD) prevention
Lipid Management and Familial Hypercholesterolaemia (FH)
We continued to support local health systems to optimise lipid management for cardiovascular disease (CVD) prevention.
This included:
- Developing education resources for the healthcare workforce to help better detect and treat patients with high cholesterol (including the genetic condition, familial hypercholesterolaemia) and associated CVD risk factors. Resources include webinars, podcasts, recordings of round-table clinical discussions, fact sheets and case studies.
- Working in collaboration with the Midlands Long Term Conditions and Prevention Clinical Network, East Midlands Integrated Care Board CVD leads, and system leaders to plan improved familial hypercholesterolaemia detection and genetic confirmation referral pathways. This work is in early development and will continue into 2024-25 and beyond.
- Supporting local adoption of lipid management pathways and NICE approved lipid lowering medications including Inclisiran, a novel injectable treatment for cardiovascular disease (CVD) which can be delivered in primary care.
Pharmacy-led lipid service
Through the Collaborative Lipid Fund (CLF), we supported a healthcare team in Derbyshire to set up a pharmacy led lipid service that was integrated across primary and secondary care based at the Derby Royal Hospital.
An independent evaluation of the service demonstrated service benefits and improvements in clinical capacity, NHS cost savings, streamlining of services and administration, patient satisfaction outcomes and increased workforce education.
Blood Pressure Optimisation
The Blood Pressure Optimisation programme (completed in September 2023) supported local systems to detect undiagnosed high blood pressure and optimise care and treatment for patients with diagnosed hypertension to reduce the incidence of heart attacks, strokes, and dementia.
We supported primary care staff to implement the Proactive Care Framework for hypertension to optimise clinical care and self-management for people with high blood pressure and other cardiovascular disease risk factors.
The Framework offers:
- Risk stratification to prioritise which patients to see first.
- Use of the wider workforce to support remote care and self-care.
- Supporting patients to maximise the benefits of remote monitoring and virtual consultations where appropriate.
In addition, we worked with ICSs to improve existing case finding initiatives to increase the detection of people with hypertension.
Learn more about Cardiovascular Disease Prevention
Return to the Impact Report